DV
Dividend Vision

JAZZ — Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC (JAZZ)

Total return is 1281.6% over the past 19.2 years, 664.0 points ahead of SPY at 617.6%. Its deepest 1-year drawdown was 11.4%.

JAZZ is a single-stock equity holding in Jazz Pharmaceuticals PLC, a pharmaceutical company. The fund does not currently pay distributions, resulting in no yield profile or dividend income component. This holding appeals primarily to investors seeking direct exposure to Jazz Pharmaceuticals' business performance rather than those focused on income generation.

JAZZ key facts

Asset type
Stock
Asset class
Equity
Inception date
06/01/2007
Distribution frequency
None
Last close
$244.96
Market cap
$15,901,474,816
Average volume
542000.0
Beta
0.364
Payout ratio
0.0
P/E ratio
16.7781
Forward P/E
10.7296
EPS
$14.60